Evidence map›Paper›PMID 38282649›Full record

ArticleJID innovations : skin science from molecules to population health2024

En Route to Targeted Ribosome Editing to Replenish Skin Anchor Protein LAMB3 in Junctional Epidermolysis Bullosa.

Bjoern Wimmer, Andreas Friedrich, Katharina Poeltner, Genevieve Edobor, Claudia Mosshammer, Gazmend Temaj, Adriana Rathner, Thomas Karl, Jan Krauss, Joerg von Hagen and 5 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in JID innovations : skin science from molecules to population health, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.6field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 3 citations in OpenAlex.

  1. Distinct responses ofMolecular therapy. Nucleic acids · 2026
    Article
  2. RiboScreenBiomedicines · 2026
    Review
  3. Review
  4. Review
  5. RiboScreenInternational journal of molecular sciences · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 6 institutions in 3 countries.

Bjoern WimmerDepartment of Biosciences and Medical Biology, University of Salzburg, Salzburg, Austria.
Andreas FriedrichDepartment of Biosciences and Medical Biology, University of Salzburg, Salzburg, Austria.
Katharina PoeltnerDepartment of Biosciences and Medical Biology, University of Salzburg, Salzburg, Austria.
Genevieve EdoborDepartment of Biosciences and Medical Biology, University of Salzburg, Salzburg, Austria.
Claudia MosshammerDepartment of Biosciences and Medical Biology, University of Salzburg, Salzburg, Austria.
Gazmend TemajFaculty of Pharmacy, College UBT, Prishtina, Kosovo.
Adriana RathnerInstitute of Biochemistry, Johannes Kepler University of Linz, Linz, Austria.
Thomas KarlDepartment of Biosciences and Medical Biology, University of Salzburg, Salzburg, Austria.
Jan KraussDepartment of Biosciences and Medical Biology, University of Salzburg, Salzburg, Austria.
Joerg von HagenMerck KGaA, Gernsheim, Germany.
Christopher GernerDepartment of Analytical Chemistry, Faculty of Chemistry, University of Vienna, Vienna, Austria.
Michael BreitenbachDepartment of Biosciences and Medical Biology, University of Salzburg, Salzburg, Austria.
Helmut HintnerDepartment of Dermatology and Allergology, University Hospital Salzburg, Salzburg, Austria.
Johann W BauerDepartment of Dermatology and Allergology, University Hospital Salzburg, Salzburg, Austria.
Hannelore Breitenbach-KollerDepartment of Biosciences and Medical Biology, University of Salzburg, Salzburg, Austria.
University of Salzburg · ATUnfallkrankenhaus Salzburg · ATJohannes Kepler University of Linz · ATMerck (Germany) · DEUniversity for Business and Technology · XKUniversity of Vienna · AT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Severe junctional epidermolysis bullosa is a rare genetic, postpartum lethal skin disease, predominantly caused by nonsense/premature termination codon (PTC) sequence variants in

Indexed as

Blistering diseaseDrug developmentEpidermolysis bullosaGenetic diseasesGenodermatoses

Identifiers

PMID38282649
PMCPMC10810840
OpenAlexW4388574744

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.